These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27221794)

  • 1. Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis.
    González-Chomón C; Silva M; Concheiro A; Alvarez-Lorenzo C
    Acta Biomater; 2016 Sep; 41():302-11. PubMed ID: 27221794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Polyvinyl Pyrrolidone-Loaded Olopatadine HCl-Laden Doughnut Contact Lens to Treat Allergic Conjunctivitis.
    Xue Y; Zhang W; Lei Y; Dang M
    J Pharm Sci; 2020 May; 109(5):1714-1724. PubMed ID: 32007507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of olopatadine for the treatment of ocular allergy.
    Abelson MB
    Expert Opin Pharmacother; 2004 Sep; 5(9):1979-94. PubMed ID: 15330735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the use of olopatadine in allergic conjunctivitis.
    McGill JI
    Int Ophthalmol; 2004 May; 25(3):171-9. PubMed ID: 15847317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.
    Kam KW; Chen LJ; Wat N; Young AL
    Ocul Immunol Inflamm; 2017 Oct; 25(5):663-677. PubMed ID: 27192186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinspired hydrogels for drug-eluting contact lenses.
    Alvarez-Lorenzo C; Anguiano-Igea S; Varela-García A; Vivero-Lopez M; Concheiro A
    Acta Biomater; 2019 Jan; 84():49-62. PubMed ID: 30448434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
    J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
    Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F
    Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A; Quintieri L
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF.
    Quan L; He H
    Mol Med Rep; 2016 Apr; 13(4):3319-25. PubMed ID: 26936233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of olopatadine and selected antihistamines with model and natural membranes.
    Brockman HL; Momsen MM; Knudtson JR; Miller ST; Graff G; Yanni JM
    Ocul Immunol Inflamm; 2003 Dec; 11(4):247-68. PubMed ID: 14704897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review.
    Zi Y; Deng Y; Ji M; Qin Y; Nong L; Liu Z; Jin M
    Medicine (Baltimore); 2020 Feb; 99(7):e18618. PubMed ID: 32049778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA; Xu SX; Yanni JM
    J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained Delivery of Olopatadine from Vitamin-E Loaded Contact Lenses.
    Reis IM; Dixon PJ; Sekar P; Chauhan A
    J Ocul Pharmacol Ther; 2024 Mar; 40(2):126-135. PubMed ID: 38489059
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis.
    Khurana S; Sharma N; Agarwal T; Chawla B; Velpandian T; Tandon R; Titiyal JS
    Eye Contact Lens; 2010 Jul; 36(4):210-4. PubMed ID: 20531202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic conjunctivitis and contact lenses: experience with olopatadine hydrochloride 0.1% therapy.
    Brodsky M
    Acta Ophthalmol Scand Suppl; 2000; (230):56-9. PubMed ID: 11057353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
    Galatowicz G; Ajayi Y; Stern ME; Calder VL
    Clin Exp Allergy; 2007 Nov; 37(11):1648-56. PubMed ID: 17877767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.